p3×FLAG-CMV-14-LanCL2 Citations (1)

Originally described in: Lanthionine synthetase C-like protein 2 (LanCL2) is a novel regulator of Akt.
Zeng M, van der Donk WA, Chen J Mol Biol Cell. 2014 Dec 1;25(24):3954-61. doi: 10.1091/mbc.E14-01-0004. Epub 2014 Oct 1. PubMed Journal

---

Articles Citing p3×FLAG-CMV-14-LanCL2

Articles
ISG12a promotes immunotherapy of HBV-associated hepatocellular carcinoma through blocking TRIM21/AKT/beta-catenin/PD-L1 axis. Deng R, Tian R, Li X, Xu Y, Li Y, Wang X, Li H, Wang L, Xu B, Yang D, Tang S, Xue B, Zuo C, Zhu H. iScience. 2024 Mar 19;27(4):109533. doi: 10.1016/j.isci.2024.109533. eCollection 2024 Apr 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.